Chemistry:Gadofosveset
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
Trade names | Vasovist, Ablavar |
Pregnancy category |
|
Routes of administration | Intravenous |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C33H40GdN3Na3O15P |
Molar mass | 975.88 g·mol−1 |
3D model (JSmol) | |
| |
|
Gadofosveset (trade names Vasovist, Ablavar) is a gadolinium-based MRI contrast agent. It was used as the trisodium salt monohydrate form.[1][2] It acts as a blood pool agent by binding to human serum albumin. The manufacturer (Lantheus Medical) discontinued production in 2017 due to poor sales.[3]
Gadofosveset facilitates high-resolution magnetic resonance angiography.[4] Ferumoxytol (trade names Feraheme, Rienso), an intravenous iron-replacement therapy, has been shown to potentially be superior to gadofosveset as a blood pool agent for MR venography in pediatric patients.[5]
References
- ↑ DailyMed: Vasovist
- ↑ Drugs.com: Ablavar
- ↑ "Gadofosveset trisodium". radiopaedia.org. https://radiopaedia.org/articles/gadofosveset-trisodium-1.
- ↑ "Gadofosveset trisodium: abdominal and peripheral vascular applications". AJR. American Journal of Roentgenology 200 (6): 1378–86. June 2013. doi:10.2214/AJR.12.8991. PMID 23701079.
- ↑ "High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol". Pediatric Radiology 52 (3): 501–512. March 2022. doi:10.1007/s00247-021-05225-2. PMID 34936018.
Original source: https://en.wikipedia.org/wiki/Gadofosveset.
Read more |